Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool

• Главные авторы: Xiao-yi Bao (Автор), Qun Zheng (Автор), Qiang Tong (Автор), Peng-chong Zhu (Автор), Zhuang Zhuang (Автор), Guo-qing Zheng (Автор), Yan Wang (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2018-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: Danshensu (DSS) possesses unique bioactivity on the cardiovascular system. However, there is a lack of systematical summary of DSS for acute myocardial ischemia injury and no quality assessment tool for the systematical review of cell experiments. Here, we aimed to assess the preclinical...